Role of NK Cell Subsets in Organ-Specific Murine Melanoma Metastasis

Tumor metastasis plays a major role in the morbidity and mortality of cancer patients. Among solid tumors that undergo metastasis, there is often a predilection to metastasize to a particular organ with, for example, prostate cancer preferentially metastasizing to bones and colon cancer preferentially metastasizing to the liver. Although many factors are thought to be important in establishing permissiveness for metastasis, the reasons for organ-specific predilection of each tumor are not understood. Using a B16 murine melanoma model, we tested the hypothesis that organ-specific NK cell subsets play a critical role in organ-specific metastasis of this tumor. Melanoma cells, given intravenously, readily colonized the lungs but not the liver. NK cell depletion (either iatrogenically or by using genetically targeted mice) resulted in substantial hepatic metastasis. Analysis of NK cell subsets, defined by the differential expression of a combination of CD27 and CD11b, indicated a significant difference in the distribution of NK cell subsets in the lung and liver with the mature subset being dominant in the lung and the immature subset being dominant in the liver. Several experimental approaches, including adoptive transfer, clearly indicated that the immature hepatic NK cell subset, CD27+ CD11b–, was protective against liver metastasis; this subset mediated its protection by a perforin-dependent cytotoxic mechanism. In contrast, the more mature NK cell subsets were more efficient at reducing pulmonary tumor load. These data indicate that organ-specific immune responses may play a pivotal role in determining the permissiveness of a given organ for the establishment of a metastatic niche.     

The ribosome modulates the structural dynamics of the conserved GTPase HflX and triggers tight nucleotide binding

The universally conserved GTPase HflX is a putative translation factor whose GTPase activity is stimulated by the 70S ribosome as well as the 50S but not the 30S ribosomal subunit. However, the details and mechanisms governing this interaction are only poorly understood. In an effort to further elucidate the functional mechanism of HflX, we examined its interaction with the 70S ribosome, the two ribosomal subunits (50S and 30S), as well as its ability to interact with guanine nucleotides in the respective ribosomal complexes using a highly purified in vitro system. Binding studies reported here demonstrate that HflX not only interacts with 50S and 70S particles, but also with the 30S subunit, independent of the nucleotide-bound state. A detailed pre-steady-state kinetic analysis of HflX interacting with a non-hydrolyzable analog of mant-GTP, coupled with an enzymatic probing assay utilizing limited trypsinolysis, reveal that HflX·GTP exists in a structurally distinct 50S- and 70S-bound form that stabilizes GTP binding up to 70 000-fold and that may represent the “GTPase-activated” state. This activation is likely required for efficient GTP-hydrolysis, and may be similar to that observed in elongation factor G. Results reported here address the surprising low affinity of free HflX for GTP and suggest that cellular HflX will mainly exist in the HflX·GTP·ribosome-bound form. A minimal model for the functional cycle of HflX is proposed.     

Anxiolytic-like action in mice treated with nitrous oxide and oral triazolam or diazepam

Few animal studies have explored the interaction of nitrous oxide (N2O) with a benzodiazepine (BNZ) administered by the oral route, as used in clinical procedures involving "conscious sedation". The purpose of this study was to evaluate the relative "anxiolytic-like" and sedative effectiveness of N2O, oral triazolam (TRIAZ; Halcion) or oral diazepam (DIAZ; Valium), either alone or in various combinations of drugs and doses. One hundred and twelve Swiss Webster male mice, 35-45 days old, were assigned to 28 groups, each of which contained four mice. The mouse staircase test was used for the assessment of anxiety (number of rearings) and sedation (number of steps ascended). Three doses of oral TRIAZ (0.1, 0.3, 1.0 mg/kg) or DIAZ (2.0, 3.5, 5.0 mg/kg) were given in combination with room air, or N2O/O2 at a N2O concentration of 25, 50 or 75%. Each mouse was tested once. N2O alone did not reduce NR in any concentration, but caused a significant increase in locomotion. DIAZ without N2O reduced NR only with the middle and high doses, but the addition of N2O significantly enhanced the anxiolytic-like effect of all DIAZ doses. TRIAZ, alone, reduced NR only in the highest dose, but added N2O resulted in anxiolytic-like behavior with all three TRIAZ doses. The sedative effects of the BNZs were extremely variable. Only the middle dose of DIAZ plus 25% N2O unequivocally reduced the number of steps ascended, i.e., caused sedation. TRIAZ lacked the inverted U-shaped dose-response relationship with NR usually seen with DIAZ. TRIAZ, therefore, provides better dose control. This behavioral animal model indicates that the optimal combinations for reduction of anxiety-like behavior with minimal effects on sedation are 0.1 mg/kg oral TRIAZ with 25% N2O or 2.0 mg/kg oral DIAZ with 25% N2O.     

The Burden of Leprosy in Cameroon: Fifteen Years into the Post-elimination Era

BackgroundCameroon achieved the elimination target of leprosy in 2000, and has maintained this status ever since. However, a number of health districts in the country continue to report significant numbers of leprosy cases. The aim of this study was to assess the burden of leprosy in Cameroon from 2000 to 2014.MethodsWe obtained and analysed using the new leprosy burden concept of analysis, leprosy surveillance data collected between 2000 and 2014 from the National Leprosy Control Programme.ConclusionThe leprosy prevalence and detection rates as well as the overall leprosy burden in Cameroon have dropped significantly between 2000 and 2014. However, a good number of health districts remain high-leprosy-burdened. The National Leprosy Control Programme should focus efforts on these health districts in the next coming years in order to further reduce the burden of leprosy in the country.     

The Glycophosphatidylinositol Anchor of the MCMV Evasin,m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition

The murine cytomegalovirus-encoded protein m157 is a cognate ligand for both inhibitory and activating receptors expressed by natural killer cells. Additionally, m157 is expressed on the surface of infected cells by a glycophosphatidylinositol (GPI) anchor. Although endogenous GPI-anchored proteins are known to be ligands for the NK cell receptor, NKG2D, the contribution of the GPI anchor for viral m157 ligand function is unknown. To determine whether the GPI anchor for m157 is dispensable for m157 function, we generated m157 variants expressed as transmembrane fusion proteins and tested cells expressing transmembrane m157 for the capacity to activate cognate Ly49 receptors. We found that the GPI anchor is required for high-level cell surface expression of m157, and that the transmembrane m157 ligand retains the capacity to activate reporter cells and NK cells expressing Ly49H, as well as Ly49I¹²⁹ reporter cells, but with reduced potency. Importantly, target cells expressing the transmembrane form of m157 were killed less efficiently and failed to mediate Ly49H receptor downregulation on fresh NK cells compared to targets expressing GPI-anchored m157. Taken together, these results show that the GPI anchor for m157 facilitates robust cell surface expression, and that NK cells are sensitive to the altered cell surface expression of this potent viral evasin.     

Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants

The development of effective immunoprophylaxis against tuberculosis (TB) remains a global priority, but is hampered by a partially protective Bacillus Calmette-Guérin (BCG) vaccine and an incomplete understanding of the mechanisms of immunity to Mycobacterium tuberculosis. Although host genetic factors may be a primary reason for BCG''s variable and inadequate efficacy, this possibility has not been intensively examined. We hypothesized that Toll-like receptor (TLR) variation is associated with altered in vivo immune responses to BCG. We examined whether functionally defined TLR pathway polymorphisms were associated with T cell cytokine responses in whole blood stimulated ex vivo with BCG 10 weeks after newborn BCG vaccination of South African infants. In the primary analysis, polymorphism TLR6_C745T (P249S) was associated with increased BCG-induced IFN-γ in both discovery (n = 240) and validation (n = 240) cohorts. In secondary analyses of the combined cohort, TLR1_T1805G (I602S) and TLR6_G1083C (synonymous) were associated with increased IFN-γ, TLR6_G1083C and TLR6_C745T were associated with increased IL-2, and TLR1_A1188T was associated with increased IFN-γ and IL-2. For each of these polymorphisms, the hypo-responsive allele, as defined by innate immunity signaling assays, was associated with increased production of TH1-type T cell cytokines (IFN-γ or IL-2). After stimulation with TLR1/6 lipopeptide ligands, PBMCs from TLR1/6-deficient individuals (stratified by TLR1_T1805G and TLR6_C745T hyporesponsive genotypes) secreted lower amounts of IL-6 and IL-10 compared to those with responsive TLR1/6 genotypes. In contrast, no IL-12p70 was secreted by PBMCs or monocytes. These data support a mechanism where TLR1/6 polymorphisms modulate TH1 T-cell polarization through genetic regulation of monocyte IL-10 secretion in the absence of IL-12. These studies provide evidence that functionally defined innate immune gene variants are associated with the development of adaptive immune responses after in vivo vaccination against a bacterial pathogen in humans. These findings could potentially guide novel adjuvant vaccine strategies as well as have implications for IFN-γ-based diagnostic testing for TB.     

The azidation of starch

Starch is an inexpensive commodity that has been used for non-food purposes for many years. Some of these uses include cross-linked starches that are synthesized with a variety of multifunctional reagents. One unexplored possibility is the use of azides for cross-linking. To this end, azide derivatives of different starches have been synthesized, including the first reported synthesis of 6-deoxy-6-azido-amylopectin. Lithium salts, which were found to not be essential for the dissolution of starch in the reaction, were replaced with sodium azide. The time for this derivatization reaction to reach completion was determined to be 1 h. N,N-dimethylacetamide was also found to be a suitable solvent. Initial experiments suggest that the azide derivative does cross-link starch when activated by heat.     

Genetic Variation in TLR Genes in Ugandan and South African Populations and Comparison with HapMap Data

Genetic epidemiological studies of complex diseases often rely on data from the International HapMap Consortium for identification of single nucleotide polymorphisms (SNPs), particularly those that tag haplotypes. However, little is known about the relevance of the African populations used to collect HapMap data for study populations conducted elsewhere in Africa. Toll-like receptor (TLR) genes play a key role in susceptibility to various infectious diseases, including tuberculosis. We conducted full-exon sequencing in samples obtained from Uganda (n = 48) and South Africa (n = 48), in four genes in the TLR pathway: TLR2, TLR4, TLR6, and TIRAP. We identified one novel TIRAP SNP (with minor allele frequency [MAF] 3.2%) and a novel TLR6 SNP (MAF 8%) in the Ugandan population, and a TLR6 SNP that is unique to the South African population (MAF 14%). These SNPs were also not present in the 1000 Genomes data. Genotype and haplotype frequencies and linkage disequilibrium patterns in Uganda and South Africa were similar to African populations in the HapMap datasets. Multidimensional scaling analysis of polymorphisms in all four genes suggested broad overlap of all of the examined African populations. Based on these data, we propose that there is enough similarity among African populations represented in the HapMap database to justify initial SNP selection for genetic epidemiological studies in Uganda and South Africa. We also discovered three novel polymorphisms that appear to be population-specific and would only be detected by sequencing efforts.     

Mechanism of estrogen-induced 17-beta-hydroxysteroid dehydrogenase in ovariectomized rat uterus

Estradiol (E2), progesterone or medroxyprogesterone acetate can induce biosynthesis of the 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD) in the mammalian uterus. For further understanding the 17-beta-HSD induction which may be mediated by the conjugation of the E2 to its receptor, premature ovariectomized rats were treated with E2, or with a synthetic steroid, diethylstilbestrol (DES), an agonist for the E2 receptor but not a substrate for 17-beta-HSD. Histological observation and uterus weight were examined as parameters to evaluate uterine response to those hormones at different durations of treatment. The 17-beta-HSD in ovariectomized rat uterus of each group was also examined by histochemical and biochemical assays. The results showed that the 17-beta-HSD activity in the uterus can be induced by E2 or DES, after daily treatment for 1, 14 and 28 days, but much higher in DES treated animals. The uterus weight demonstrated a "negative linear correlation" to the enzyme activity in all E2 treated groups, but not in DES or control rats. Accordingly, it was indicated that the 17-beta-HSD induction was regulated by conjugation of E2 or DES to its receptor. Therefore, we believe that the 17-beta-HSD gene in the rat uterus is another estrogen responsive gene.